Skip to main content
Fig. 4 | Cardio-Oncology

Fig. 4

From: Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers

Fig. 4

Linear Mixed Model Predictions of Biomarker Concentrations. a and b Linear mixed model analysis of hsTnI concentrations on the day following doxorubicin infusion demonstrated no significant difference between treatment arms or outcome groups. c Linear mixed model analysis of NT-proBNP concentrations on the day following doxorubicin infusion demonstrated significantly higher concentrations in the treatment arm receiving sildenafil

Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us